Drug Trial Radar · NCT07230860
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
189
Actual
Start
Jan 20, 2026
Primary completion
Nov 19, 2026
Study completion Feb 10, 2028
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Nov 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess how well JNJ-95597528 works compared to placebo in participants with moderate to severe atopic dermatitis (AD).
Conditions
- Dermatitis, Atopic
Interventions
JNJ-95597528Drug
JNJ-95597528 will be administered subcutaneously.
PlaceboDrug
Placebo will be administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants with Eczema Area and Severity Index (EASI) 75 Response at Week 12Time frame: Week 12
Locations
62 sites in 9 countries. Site status is shown where the registry gives one.
First OC Dermatology
Fountain Valley, California
University of California Los Angeles - Division of Dermatology
Los Angeles, California
Southern California Dermatology
Santa Ana, California
Driven Research LLC
Miami, Florida
Arlington Dermatology
Rolling Meadows, Illinois
Dawes Fretzin Clinical Research Group
Indianapolis, Indiana
Henry Ford Health System
Detroit, Michigan
Red River Research Partners LLC
Fargo, North Dakota
Oregon Dermatology and Research Center
Portland, Oregon
Clinical Research Philadelphia
Philadelphia, Pennsylvania
Center for Clinical Studies
Houston, Texas
Progressive Clinical Research
San Antonio, Texas
Instituto Medico De Alta Complejidad (IMAC)
Buenos Aires, Argentina
CIPREC
Buenos Aires, Argentina
DOM Reumatologia
Buenos Aires, Argentina
INAER - Investigacion en Alergias y Enfermedades Respiratorias
Buenos Aires, Argentina
Derma Internacional S A
Buenos Aires, Argentina
Mautalen Salud e Investigacion
CABA, Argentina
Instituto de Investigaciones Clinicas Cordoba
Córdoba, Argentina
Centro de Investigaciones Clinicas CIC IESR
Rosario, Argentina
Centro Respiratorio Infantil
Rosario, Argentina
Centro de Investigaciones Medicas Tucuman
San Miguel de Tucumán, Argentina
Ceti - Centro de Estudos Em Terapias Inovadoras
Curitiba, Brazil
Hospital De Clinicas De Porto Alegre
Porto Alegre, Brazil
Instituto Brasil de Pesquisa Clinica
Rio de Janeiro, Brazil
Pesquisare Saude
Santo André, Brazil
PSEG trials Centro de Pesquisa Clinica S A
São Paulo, Brazil
Cepes - Fmabc
São Paulo, Brazil
Dermatology Research Institute Inc
Calgary, Alberta, Canada
CCA Medical Research Corporation
Ajax, Ontario, Canada
SimcoDerm Medical and Surgical Dermatology Centre
Barrie, Ontario, Canada
Dr Wei Jing Loo Medicine Professional Corporation
London, Ontario, Canada
DermEdge Research
Mississauga, Ontario, Canada
Allergy Research Canada Inc.
Niagara Falls, Ontario, Canada
York Dermatology Clinic and Research Centre
Richmond Hill, Ontario, Canada
XLR8 Medical Research
Windsor, Ontario, Canada
China Japan Friendship Hospital
Beijing, China
Xiangya Hospital Central South University
Changsha, China
Hosp. of Chengde Medical University
Chengde, China
West China Hospital of Sichuan University
Chengdu, China
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.